GLPG-0187
CAS No. 1320346-97-1
GLPG-0187 ( GLPG 0187;GLPG0187 )
Catalog No. M11294 CAS No. 1320346-97-1
GLPG-0187 (GLPG0187) is a highly potent, broad spectrum integrin receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 95 | In Stock |
|
10MG | 140 | In Stock |
|
25MG | 237 | In Stock |
|
50MG | 350 | In Stock |
|
100MG | 521 | In Stock |
|
500MG | 1134 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGLPG-0187
-
NoteResearch use only, not for human use.
-
Brief DescriptionGLPG-0187 (GLPG0187) is a highly potent, broad spectrum integrin receptor antagonist.
-
DescriptionGLPG-0187 (GLPG0187) is a highly potent, broad spectrum integrin receptor antagonist with IC50 of 1-10 nM for αvβ1, αvβ3, αvβ5, αvβ6, αvβ8 and α5β1; significantly inhibits angiogenesis both in vivo and in vitro, osteoclastogenesis in vitro, and bone loss in vivo; inhibits de novo formation and progression of bone and visceral metastases in prostate cancer and breast cancer mice models.Solid Tumors Phase 1 Clinical
-
SynonymsGLPG 0187;GLPG0187
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
Recptorαvβ1integrin
-
Research AreaCancer
-
IndicationSolid Tumors
Chemical Information
-
CAS Number1320346-97-1
-
Formula Weight595.71
-
Molecular FormulaC29H37N7O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 15 mg/mL
-
SMILESO=C(O)[C@H](CNC1=NC(C)=NC(N2CCC(C3=NC4=C(CCCN4)C=C3)CC2)=C1C)NS(=O)(C5=CC=C(OC)C=C5)=O
-
Chemical NameL-Alanine, 3-[[2,5-dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(4-methoxyphenyl)sulfonyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pujuguet P, et al. Eur J Cancer. 2011;47:S28. doi: 10.1016/S0959-8049(11)72695-8.
2. Cirkel GA, et al. Invest New Drugs. 2016 Apr;34(2):184-92.
3. van der Horst G, et al. Neoplasia. 2011 Jun;13(6):516-25.
4. Reeves KJ, et al. Int J Cancer. 2015 Apr 1;136(7):1731-40.
2. Cirkel GA, et al. Invest New Drugs. 2016 Apr;34(2):184-92.
3. van der Horst G, et al. Neoplasia. 2011 Jun;13(6):516-25.
4. Reeves KJ, et al. Int J Cancer. 2015 Apr 1;136(7):1731-40.
molnova catalog
related products
-
DS-70
DS-70 (α4 integrin inhibitor DS-70) is a novel potent α/β- peptidomimetic antagonist of α4 integrin.
-
Arg-Gly-Asp TFA
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion addresses certain cell lines and elicits specific cell responses; binds to?integrins.
-
Integrin-IN-27
A potent integrin αvβ3 antagonist with IC50 of 18 nM; could be conjugated to paclitaxel for selective delivery to alphavbeta3 positive metastatic cancer cells.